ClearSign director reports 24,621 RSUs at $0.00; post-grant 70,266
Rhea-AI Filing Summary
ClearSign Technologies (CLIR) reported a director equity transaction. On 10/01/2025, a non‑executive director acquired 24,621 restricted stock units (RSUs) at $0.00 under the company’s 2021 Equity Incentive Plan as compensation for the quarter ending December 31, 2025.
The RSUs vest upon the first to occur of a change in control, disability, death, or separation from service. After this grant, the reporting person directly beneficially owned 70,266 derivative securities.
Positive
- None.
Negative
- None.
Insights
Routine director RSU grant; neutral impact.
ClearSign Technologies reported a director equity award of 24,621 RSUs on 10/01/2025 at $0.00 (standard for RSUs). This aligns with customary board compensation and does not itself change cash balances.
Vesting is contingent on specified events: Change in Control, Disability, death, or separation from service, as described. Post-transaction holdings show 70,266 derivative securities beneficially owned directly.
This filing records equity compensation and ownership. Actual impact depends on vesting events and future share delivery mechanics disclosed in subsequent company materials.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 24,621 | $0.00 | -- |
Footnotes (1)
- As compensation for services as a non-executive director during the quarter ending December 31, 2025, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting person's death; or (4) the reporting person's separation from service.
FAQ
What did CLIR disclose in this Form 4?
How many RSUs were granted to the CLIR director and at what price?
What are the vesting conditions for the RSUs reported by CLIR?
What is the director’s derivative holdings after the transaction?
What plan governs the RSU grant reported by CLIR?
What is the relationship of the reporting person to CLIR?